Tolerance of bradykinin-releasing drugs in patients with acquired C1 inhibitor deficiency: a case series and review of the literature

Eur J Dermatol. 2022 Feb 1;32(1):49-55. doi: 10.1684/ejd.2021.4175.
No abstract available

Publication types

  • Review

MeSH terms

  • Angioedema* / chemically induced
  • Angioedemas, Hereditary* / drug therapy
  • Bradykinin
  • Complement C1 Inhibitor Protein
  • Humans
  • Transcription Factors

Substances

  • Complement C1 Inhibitor Protein
  • Transcription Factors
  • Bradykinin